RECRUITING

Systemic Lidocaine Versus Ultrasound-guided Adductor Canal Block for Patients Undergoing Total Knee Arthroplasty

Description

The investigators are evaluating the postoperative outcomes in patients undergoing total knee arthroplasty that receive either systemic lidocaine or ultrasound-guided adductor canal block as part of their anesthetic plan.

Conditions

Arthroplasty, Replacement, KneeTotal Knee Arthroplasty
Talk to us

Related Conditions:

Arthroplasty, Replacement, KneeTotal Knee Arthroplasty

Study Overview

On this page

Study Details

Study overview

The investigators are evaluating the postoperative outcomes in patients undergoing total knee arthroplasty that receive either systemic lidocaine or ultrasound-guided adductor canal block as part of their anesthetic plan.

The Efficacy of Systemic Lidocaine Versus Ultrasound-guided Adductor Canal Block for Patients Undergoing Total Knee Arthroplasty: a Randomized, Double-blinded, Non-inferiority Study

Systemic Lidocaine Versus Ultrasound-guided Adductor Canal Block for Patients Undergoing Total Knee Arthroplasty

Condition
Arthroplasty, Replacement, Knee
Intervention / Treatment

-

Contacts and Locations

Providence

Rhode Island Hospital, Providence, Rhode Island, United States, 02903

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * ASA PS 1-3 patients undergoing primary, unilateral total knee arthroplasty
  • * ASA PS classification of 4 or greater
  • * Pre-existing neuropathy
  • * Coagulopathy
  • * Chronic opioid consumption (\>3 months)
  • * Infection at the site
  • * Known allergy to study medications (lidocaine)
  • * High grade atrioventricular block (cardiac conduction system impairment)
  • * A history of CVA/TIA
  • * Currently using lidocaine patches
  • * Known liver disease

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Rhode Island Hospital,

Vendhan Ramanujam, M.D., PRINCIPAL_INVESTIGATOR, Rhode Island Hospital, Brown University

Study Record Dates

2024-11-30